2 weeks Ago By Defense World Staff
Evogene ( TSE:EVGN – Get Free Report ) had its price target lowered by research analysts at Ventum Financial from C$4.00 to C$3.00 in a research report issued to clients and investors on Friday, BayStreet.
CA reports. Evogene Price Performance Evogene Company Profile ( Get Free Report ) Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements.
See Also Five stocks we like better than Evogene What is the Shanghai Stock Exchange Composite Index? Vertiv’s Cool Tech Makes Its Stock Red-Hot Investing In Automotive Stocks MarketBeat Week in Review – 11/18 – 11/22 Technology Stocks Explained: Here’s What to Know About Tech 2 Finance Stocks With Competitive Advantages You Can’t Ignore Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter ..
